Every study has an endpoint. Ours is a decision you can defend
Research built for the scrutiny of healthcare
In healthcare, a brand plan, a launch sequence or a pricing decision can rest on what a few hundred clinicians say. That evidence will be questioned by your leadership, your medical colleagues and, often, by payers. It has to hold.
Endpoint exists to make sure it does. Our researchers come from medical publishing and healthcare communication, and have spent years working alongside clinicians, pharmacists and the companies that serve them. We know how treatment decisions are made in each country, we write questions that specialists recognise as their own world, and we treat every respondent and every data point as something that will be challenged later.
Right respondents
Every healthcare professional is checked against professional registers before taking part. Fewer, real experts beat a larger sample of the wrong people.
Clinical fluency
We read the literature and the guidelines before we write a question, so the survey makes sense to a cardiologist, a hospital pharmacist or an orthoptist.
Compliance by design
Double-blind fieldwork, UK and EU data protection and adverse event reporting are part of every study from the first day, not a checklist at the end.
Research for every stage of a product's life
Every study starts with the decision it has to support. From there we choose the method, the audience and the markets, and we tell you plainly when a simpler design will answer the question.
Quantitative research
Online surveys with verified healthcare professionals and patients: awareness, trial and usage studies, concept and message testing, segmentation, demand estimation and pricing research, with sample sizes that stand up to statistical scrutiny.
Qualitative research
In-depth interviews, online and in-person groups, and observation in clinics, pharmacies and hospitals, led by native-speaking moderators who can follow a specialist's reasoning.
Patient and caregiver research
Patient journeys, unmet needs, adherence and treatment experience, handled with the extra care that health data and sensitive conversations deserve.
Market access and pricing
Interviews with payers, HTA experts, hospital pharmacists and procurement teams to test value stories, comparators and price points before you face them for real.
Launch and brand tracking
Pre-launch baselines and repeated waves that show how awareness, perception and use evolve, with methods kept consistent so movements reflect the market, not the survey.
Medical affairs insights
How clinicians receive new evidence, where uncertainty remains and what they still need to know, kept strictly separate from promotional activity.
Fieldwork and survey management
Programming, multilingual hosting, invitations, participant support, incentive payments and quality control, for studies where you provide the questionnaire or the contacts.
Analysis and reporting
Clean data, tables, coding of open answers, statistical analysis and reports written for decision-makers, with the executive summary first and the evidence after.
Across the full range of human health
Every therapy area has its own prescribers, patient pathways and access rules. Before we write a single question, we review the current guidelines, recent trials and the treatment pathway in each country of the study.
Oncology · Haematology · Cardiovascular · Diabetes, obesity and metabolism · Endocrinology · Immunology and rheumatology · Dermatology · Neurology · Psychiatry and mental health · Respiratory · Infectious diseases · Vaccines · Rare diseases · Ophthalmology and eye care · Gastroenterology and hepatology · Nephrology and urology · Women’s health and fertility · Paediatrics · Pain and anaesthesia · Dental and oral health · Medical devices and diagnostics · Consumer health and OTC · Digital health.
Working in a niche we have not listed? Tell us about it. The principles are the same: understand the pathway, find the right people, ask the right questions.
The people behind every treatment decision
A GP spots the symptoms, a specialist confirms the diagnosis, a nurse explains the treatment, a pharmacist dispenses it, a payer decides whether it is funded and a patient decides whether to keep taking it. Good research brings those perspectives together.
Specialists and GPs
Hospital and office-based physicians in every specialty, screened by sub-specialty, setting, patient volume and treatment experience.
Pharmacists
Community and hospital pharmacists, formulary decision-makers and pharmacy chain buyers.
Eye care professionals
Ophthalmologists, optometrists, orthoptists and opticians, with roles mapped country by country.
Nurses and allied health professionals
Specialist and practice nurses, physiotherapists, dietitians, midwives, dentists and laboratory scientists.
Payers and decision-makers
Reimbursement and HTA experts, hospital directors, procurement teams and budget holders.
Patients and caregivers
People living with chronic and rare conditions and those who care for them, reached with explicit consent.
From brief to decision
Brief
We start with the business decision behind the research, the audience, the markets and the timeline.
Proposal
You receive a clear proposal with method, sample, timings and a fixed fee, usually within 48 hours.
Design
We draft or refine the questionnaire or discussion guide with you, then translate and test it in every language.
Fieldwork
We invite and verify respondents, monitor quality every day and keep you updated by market.
Analysis
We clean the data, build the tables and turn the findings into a report your team can use.
Debrief
We present the results and stay available for the questions that come afterwards.
Ready for your supplier assessment
We know your procurement and compliance teams will ask hard questions. Here are our answers.
Verified respondents
Identity, professional registration and place of practice are checked before anyone takes part, and profiles are re-checked over time.
Clean data
Every interview is checked for speeding, straight-lining, contradictions, duplicates and meaningless answers. Weak interviews are removed and replaced at our cost.
Double-blind by default
Clients receive anonymised data only. Names, contact details and payment details stay with us.
UK and EU data protection
We work under the UK GDPR, the Data Protection Act 2018 and the EU GDPR, with data processing agreements, secure storage and clear retention rules.
Adverse event reporting
Adverse events, product complaints and special situations are reported to the sponsor within agreed timelines, by a team trained on your procedure.
Industry codes
Our studies follow the EphMRA Code of Conduct, the BHBIA Legal and Ethical Guidelines, the MRS Code of Conduct and the ICC/ESOMAR International Code. Research is never used to promote products.
You own the client, the design and the story. We make sure the right respondents turn up, the data is clean and the timeline holds. Agencies work with us for recruitment, survey programming, multilingual hosting, moderation, incentive management and data processing, under their own brand.
Your fieldwork partner in Europe
Feasibility and quote within 24 hours on working days.
Invisible to your client: we never contact your end client.
Honest numbers: if a quota looks unrealistic, we say so before you promise it.
Your experience can shape better care
Are you a physician, pharmacist, nurse, optometrist, orthoptist, optician or other healthcare professional? Join our research panel and take part in paid online surveys and interviews about medicines, devices and services.
Paid for your time
compensation is stated before you start.
Your choice
accept only the studies that interest you.
Your identity protected
we never share your name or contact details with the companies that commission research.
Eye care professionals
no sales calls, no promotion.
Researchers who speak the language of medicine
Endpoint is the healthcare market research practice of Puffin Partners Ltd, based in London. Our team comes from medical publishing and healthcare communication, with years of daily work alongside clinicians, pharmacists and pharmaceutical companies across Europe.
That background shapes how we work. We write questions clinicians take seriously, we know which details matter in a treatment pathway, and we respect the time of the professionals we interview, because we have worked with them for years.
Why “Endpoint”? In a clinical study, the endpoint is the outcome that matters, the one that decides what happens next. We see every research project the same way: a question that deserves an answer you can act on.
FAQ
Questions we are often asked
We are a healthcare market research agency based in London. We run quantitative and qualitative research with healthcare professionals, patients and payers for pharmaceutical, biotech and medical device companies, and fieldwork for other research agencies.
The United Kingdom, France, Germany, Spain, Italy and other European markets, with multi-country studies coordinated by one team.
We check identity, registration with the relevant professional body and place of practice before anyone takes part, and every completed interview goes through quality checks.
No. Clients receive anonymised data. Names, contact details and payment details stay with us.
Yes. We can program and host your questionnaire, manage invitations to your contacts under a data processing agreement, pay incentives and analyse the results.
Yes. Adverse events, product complaints and special situations are reported to the sponsor within the agreed timelines.
Usually within 48 hours of receiving a brief.
Join our panel through the form on this page. Taking part is voluntary, paid and confidential.
Tell us what you need to know
Share your brief, even if it is still a rough idea. A researcher will reply within one working day with questions, options and a realistic plan. Everything you send us is confidential.
